| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of MELK protein | affects expression | 20106945
|
| C015001 |
arsenite |
arsenite results in decreased expression of MELK mRNA | decreases expression | 18929588
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MELK mRNA | decreases expression | 20064835
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MELK mRNA | decreases expression | 20382639 19150397
|
| C006780 |
bisphenol A |
bisphenol A results in increased expression of MELK mRNA | increases expression | 16474171
|
| D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of MELK mRNA | affects expression | 17484886
|
| D003345 |
Corticosterone |
Corticosterone results in decreased expression of MELK mRNA | decreases expression | 15755911
|
| D003520 |
Cyclophosphamide |
MELK mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MELK mRNA | decreases expression | 20106945
|
| D004317 |
Doxorubicin |
MELK mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
| D004958 |
Estradiol |
Estradiol results in increased expression of MELK mRNA | increases expression | 16474171 20106945
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of MELK mRNA | increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MELK mRNA | affects cotreatment|increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of MELK mRNA | affects expression | 17351261
|
| D005472 |
Fluorouracil |
MELK mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
| D005472 |
Fluorouracil |
MELK protein affects the susceptibility to Fluorouracil | affects response to substance | 15548681
|
| D019833 |
Genistein |
Genistein results in increased expression of MELK mRNA | increases expression | 16474171
|
| D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of MELK mRNA | increases expression | 20713471
|
| D017239 |
Paclitaxel |
MELK mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
| D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in increased expression of MELK mRNA | increases expression | 16474171
|
| C017947 |
sodium arsenite |
sodium arsenite inhibits the reaction [E2F1 protein binds to MELK promoter] | affects binding|decreases reaction | 17998272
|
| C017947 |
sodium arsenite |
sodium arsenite promotes the reaction [E2F4 protein binds to MELK promoter] | affects binding|increases reaction | 17998272
|
| C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of MELK mRNA | decreases expression | 17998272
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MELK mRNA | increases expression | 20106945
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MELK mRNA | affects cotreatment|increases expression | 17942748
|
| D014747 |
Vinblastine |
MELK protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.76 | 15322242 11752688 14514962 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.86 | 17505938 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
16.85 | 20127859 20464547 |
| MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
16.85 | 17418594 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
16.85 | 11473722 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
16.85 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
16.85 | 17638652 |
| MESH:D000230 |
Adenocarcinoma |
|
Genistein |
16.85 | 11473722 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.70 | 6695378 |
| MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
6.70 | 10545420 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.62 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.82 | 16712894 17306315 |
| MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.46 | 21441931 |
| MESH:D000740 |
Anemia |
|
Fluorouracil |
8.42 | 16511603 17963324 15504547 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.42 | 11748828 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.99 | 19183758 |
| MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
9.88 | 15014928 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
9.88 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.61 | 15885639 |
| MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.40 | 11922910 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.96 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.71 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.71 | 15746008 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.62 | 14601052 |
| MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.48 | 15867366 |
| MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.78 | 11985600 |
| MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.73 | 17150277 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
6.95 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
6.95 | 17123778 |
| MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
6.95 | 15136595 17388661 17020986 12006526 15093573 11325840 16978400 18234424 18323546 |
| MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
6.95 | 11325840 15668708 17426702 15136595 15567936 16096432 15994142 15939500 16264153 18695136 18382427 19526202 17983394 18628466 15634643 18234424 16322301 15993339 16935488 16826403 16115903 16595493 15692762 17369602 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
6.95 | 17289903 17261762 12948864 16675129 14630087 17018787 18497071 19861407 |
| MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
6.95 | 19217205 16557594 15136595 18357371 18608205 16595493 16110121 |
| MESH:D001943 |
Breast Neoplasms |
|
Genistein |
6.95 | 16873071 16541309 17200150 |
| MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
6.95 | 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
6.95 | 11325840 16273361 18223236 15136595 18323546 16244791 16115903 18234424 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.95 | 20435547 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.38 | 16111702 |
| MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.69 | 18705752 15700767 16011737 16227642 16050911 16097048 16192424 15673190 3786805 16124888 10355542 15721981 |
| MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
12.08 | 16051944 |
| MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
12.08 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Fluorouracil |
13.57 | 17121937 |
| MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
13.57 | 10545420 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
13.57 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
19.67 | 12619106 21507988 12907637 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
19.67 | 18788625 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
19.67 | 19701751 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
19.67 | 18059187 17876044 16023760 16234567 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
19.67 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
19.67 | 16799960 16332177 17971768 17045692 18930000 17088986 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
19.67 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
19.67 | 16313753 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
19.67 | 17306315 15276417 16507464 |
| MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.90 | 17123778 |
| MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.80 | 16152834 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
15.11 | 16201981 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
15.11 | 16201981 1485588 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
15.11 | 18695887 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
15.11 | 1485588 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.60 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
10.60 | 6189445 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
10.60 | 16280240 17066447 16757204 18986760 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.60 | 18572023 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.32 | 16120746 18850075 18670907 |
| MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.47 | 17007740 16364871 16952015 17308081 16242529 15476868 17382496 17351982 16651473 16455267 17974986 17519947 16278810 18627295 16612575 17329180 17928571 16109756 17924179 15505089 15792986 17131338 15811867 16731534 16269455 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.92 | 16243910 17334414 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.24 | 16332659 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
20.45 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
20.45 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
20.45 | 18566989 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
20.45 | 16192471 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
20.45 | 20056578 19524636 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.08 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.56 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.56 | 17681005 16919318 16105132 11677210 17333356 17110522 15861022 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.07 | 8697196 12621046 15340226 15668235 16354765 |
| MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
5.82 | 15037631 |
| MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.82 | 16510598 18772588 15001691 17018589 17725105 17172411 17169374 16340194 17287894 17016597 |
| MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.82 | 17182828 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
6.43 | 18802399 18259882 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
6.43 | 16303861 17094418 18383874 18949393 20501625 16391804 18802399 15289873 17401013 17255274 17454858 17594712 16282729 18288408 16331619 17016601 15148649 14970324 18509181 16524972 17695437 18448328 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
6.43 | 18802399 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
6.43 | 15531428 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
6.43 | 18802399 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 20055451 15322242 |
| MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.90 | 16614059 12161096 18372110 18710439 12913760 17010015 15643279 16989017 10700343 17979934 12388444 16651033 10498854 11948286 15276878 18483878 18433785 18295254 16413132 18093676 |
| MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.71 | 16733453 |
| MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.62 | 16140633 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.99 | 11751995 15331540 10990075 |
| MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.19 | 18772604 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.26 | 16647724 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.26 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.33 | 19279558 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
6.09 | 19336974 7440962 3786805 9327722 15998439 16177239 7179309 4309450 3732212 2869522 6884620 21278145 6623471 19085960 11566570 15968718 16227642 10915739 15027814 17522070 7120509 10092053 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.09 | 17416283 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.09 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.89 | 18602426 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.89 | 11462148 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.30 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.82 | 16714409 15322242 18230668 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.10 | 12538720 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.50 | 16402032 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
12.18 | 17359293 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.18 | 18566989 11473722 19148513 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
12.18 | 11473722 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.94 | 9294722 10568697 |
| MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.08 | 18037988 |
| MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.13 | 11006010 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.24 | 20426865 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
10.24 | 16530937 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
10.24 | 16337965 16481741 15173087 16785472 17638652 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
10.24 | 16481741 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.95 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
arsenite |
18.11 | 18296743 |
| MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
18.11 | 17595544 16045604 16239168 15959796 19224547 12631006 61145 12795759 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.11 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
18.11 | 15345470 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.37 | 11858732 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.50 | 19069698 |
| MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.85 | 10962813 14633661 |
| MESH:D005355 |
Fibrosis |
|
arsenite |
20.45 | 18296743 |
| MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
20.45 | 18705752 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
20.45 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
20.45 | 20067830 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.59 | 16452187 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.13 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.14 | 17150277 |
| MESH:D005909 |
Glioblastoma |
|
Genistein |
7.14 | 16598420 |
| MESH:D005910 |
Glioma |
|
Fluorouracil |
2.83 | 16145905 |
| MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.43 | 11389073 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.51 | 10696789 |
| MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.95 | 16376943 15172196 11014644 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.72 | 15692506 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.72 | 15162350 18337622 15102660 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.29 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.29 | 11294989 10048152 |
| MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.42 | 17888722 16495754 18674790 18006777 16144979 16879835 16330681 16244371 16244372 14766674 16707910 17875725 12587719 |
| MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.29 | 17481944 |
| MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.82 | 15692506 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.34 | 15720958 |
| MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.20 | 11918545 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.25 | 11000095 |
| MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.45 | 14986274 |
| MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.51 | 19110552 19900420 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.81 | 16120746 15340226 12621046 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.95 | 15709030 |
| MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
16.91 | 17606976 16135485 |
| MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
16.91 | 17606976 18501091 15147373 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
16.91 | 12676792 |
| MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
16.91 | 18501091 18180244 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.67 | 17088409 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.96 | 8697196 18606429 16959395 15340226 16354765 |
| MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.45 | 16899240 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.83 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.83 | 18670907 18850075 |
| MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.00 | 15338365 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.72 | 16945680 16569931 |
| MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.25 | 16076520 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.38 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
10.94 | 7193160 16517039 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
10.94 | 17937319 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
10.94 | 12646999 15346721 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.81 | 12200463 12878042 |
| MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.24 | 16393666 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.24 | 16393666 16627594 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.25 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.36 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.04 | 18776723 10903974 8314463 |
| MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
14.04 | 16775033 15699352 15369732 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
14.04 | 15618244 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
14.04 | 20008137 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.07 | 16707910 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.98 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.98 | 15610895 |
| MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
11.98 | 16985049 |
| MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.53 | 10602166 |
| MESH:D007938 |
Leukemia |
|
Genistein |
6.53 | 18980019 17468513 |
| MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.08 | 16085563 |
| MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.46 | 17008537 18587576 17658394 17296974 18172266 17802794 |
| MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.02 | 10373061 |
| MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.88 | 10052129 11830472 |
| MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.74 | 17353645 |
| MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
6.67 | 18296743 |
| MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.67 | 21278145 16943688 11903743 17157831 11408273 16239168 17334410 16221502 17174718 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.62 | 17976157 15362042 15893842 15931870 13678700 12898905 17944888 17708605 17823541 12649538 16033810 12445418 18205269 16136751 18481824 17805973 17900296 18210741 17766677 18376398 11481614 17557913 16116963 15673190 14620537 18251166 16097048 17698563 12958196 15925388 10355542 17761835 15052691 18412020 18279442 17481882 20821823 12741479 15650968 12586293 18166357 18054572 14724832 16638106 15959796 18277467 14512876 12546737 17640975 15996030 12445421 16248980 18006644 17922224 14716833 18472332 17565644 16015684 18263696 14748882 15370692 18395914 15876570 15818738 12666154 12632514 18418968 12389079 16192424 18472094 12632512 17714472 17631135 18339082 17721639 15730626 18317297 15338365 17525996 17869086 18705752 18429990 12667390 15123356 12609069 16027843 18395095 18156304 18420326 15057751 16011737 14716496 18187930 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.62 | 16439617 16595196 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.62 | 14716833 14659978 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.62 | 17823541 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.62 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.06 | 15830285 16246199 17285989 16964402 15720792 |
| MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.08 | 15123358 |
| MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.61 | 16899240 14706259 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
17.56 | 18177683 2125692 15890375 9163691 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
17.56 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
17.56 | 19294768 |
| MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
17.56 | 15113037 17045692 18383874 16603448 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
17.56 | 15276417 16712894 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
17.56 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
22.67 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
22.67 | 15583823 12014681 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
22.67 | 17085340 16842330 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
22.67 | 1399818 598648 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
22.67 | 1423854 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
22.67 | 12151625 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.11 | 19095001 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
12.83 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenite |
12.83 | 16809336 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
12.83 | 18816296 6695378 20464547 20135361 18569708 17053015 20064080 18520028 20869020 |
| MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
12.83 | 17418594 6189445 |
| MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
12.83 | 15246190 |
| MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
12.83 | 16271038 17909032 9230183 16337739 7750092 6695378 20970405 11893704 15390079 20512841 1399818 10545420 21163286 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
12.83 | 16712894 17077188 17306315 15276417 19931552 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
12.83 | 19555203 11884234 |
| MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.71 | 15086387 |
| MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
7.67 | 12854902 |
| MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.67 | 16098063 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.51 | 16675587 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
14.25 | 11911406 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
14.25 | 17654614 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
14.25 | 14749477 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.48 | 15621674 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
13.87 | 12807724 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
13.87 | 15458769 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
13.87 | 11807958 17203775 16891317 11408345 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
13.87 | 14578162 12929590 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.40 | 19453300 |
| MESH:D008545 |
Melanoma |
|
Doxorubicin |
7.26 | 16827129 |
| MESH:D008545 |
Melanoma |
|
Paclitaxel |
7.26 | 12040289 12025231 16342250 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
7.26 | 19082730 16487513 |
| MESH:D008545 |
Melanoma |
|
Vinblastine |
7.26 | 15577323 16432458 18332650 15577320 18176117 12374674 16809738 18505091 17761969 16248763 |
| MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.71 | 16388313 |
| MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.02 | 17638057 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.71 | 16801185 |
| MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.42 | 15792986 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.30 | 16381670 |
| MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.30 | 16757204 18986760 |
| MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.70 | 17415656 |
| MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.62 | 14749477 |
| MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.85 | 19429709 15857846 |
| MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.85 | 17141266 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.95 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.28 | 16810080 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.28 | 17141266 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.02 | 18259882 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
6.02 | 15867366 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
11.55 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
11.55 | 18854779 |
| MESH:D009369 |
Neoplasms |
|
Fluorouracil |
11.55 | 16928823 18239605 18600527 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
11.55 | 11559025 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.58 | 20056578 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
9.87 | 15738583 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
9.87 | 17289903 |
| MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.68 | 16899518 16636307 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.36 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.04 | 19348381 18481113 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.04 | 16889571 15640375 |
| MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
22.74 | 11399458 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
22.74 | 16427766 11399458 |
| MESH:D009421 |
Nervous System Malformations |
|
Genistein |
22.74 | 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
22.74 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.08 | 12854658 |
| MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
7.06 | 16115947 15176712 8761367 |
| MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.06 | 15555623 |
| MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.80 | 8761367 12837982 |
| MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.38 | 16436463 |
| MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
9.47 | 8291058 |
| MESH:D009503 |
Neutropenia |
|
Vinblastine |
9.47 | 17378895 |
| MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.63 | 16517039 |
| MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.89 | 15867366 |
| MESH:D010024 |
Osteoporosis |
|
Genistein |
3.20 | 19401787 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.00 | 16169203 |
| MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.04 | 15930896 |
| MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.90 | 11985600 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.11 | 19401270 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
11.11 | 19005980 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
11.11 | 11161223 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
11.11 | 17306315 15276417 |
| MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.55 | 12161096 18093676 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
5.50 | 11332152 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.50 | 16929163 19003803 16500647 15113037 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.60 | 11578682 |
| MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
3.36 | 16702228 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.17 | 12520081 |
| MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.08 | 17983394 |
| MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.08 | 17638057 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.47 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.14 | 12371664 |
| MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.75 | 21297632 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.22 | 10548101 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.22 | 11118676 11399792 11896295 11222880 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.28 | 20887781 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.28 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.54 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.54 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.54 | 17136230 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.54 | 15897917 16868541 16729912 15749863 18437689 16888761 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.54 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.54 | 18626508 19082440 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
3.54 | 16925846 15256057 15378649 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
3.54 | 17172428 16356831 16729912 17136230 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
3.54 | 15721890 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.54 | 16039940 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.23 | 15861022 16919318 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.20 | 16882103 |
| MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.70 | 10548101 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.25 | 16636934 |
| MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.93 | 15538739 18286688 16160472 18722050 |
| MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.13 | 17922066 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 18990726 |
| MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.91 | 17203757 15675481 17710206 18313854 16767912 15625365 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.16 | 16326096 14601052 |
| MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.70 | 17846226 |
| MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.74 | 16636934 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.23 | 19755658 10029692 |
| MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.23 | 15692506 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.23 | 19524636 18572023 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.23 | 16192470 |
| MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.48 | 15625365 17203757 16767912 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.86 | 16709447 |
| OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.43 | 16517039 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.73 | 12854658 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.40 | 2093021 20155912 |
| MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.40 | 18396642 19084572 16951190 18567086 19015929 17498489 16424979 15786421 17522103 17172411 |
| MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
3.40 | 18396642 18506536 |
| MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.90 | 16045194 16684133 |
| MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.97 | 12837982 |
| MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.73 | 16930453 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.54 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.07 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.82 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.30 | 16010429 17909728 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.60 | 19048282 |
| MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.91 | 16280240 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.70 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
11.70 | 14692829 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
11.70 | 17653716 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.70 | 17306315 11723127 16452187 16712894 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.22 | 16803524 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.22 | 11813266 |
| MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.93 | 14652134 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.21 | 14692618 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.90 | 1336536 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
4.96 | 15577323 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.34 | 17056641 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.51 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.46 | 14671159 15869587 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.13 | 17678736 16364871 17334414 17638931 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.17 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.36 | 17120751 |